NCT02557295View on ClinicalTrials.gov

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

TerminatedOBSERVATIONAL

Enrollment

248

Participants

Timeline

Start Date

December 17, 2013

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions

Rheumatoid Arthritis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY